By Godson Umejiego, Bureau Chief, The Americas
A leading healthcare investment banking firm, Provident Healthcare Partners (Provident),announced it has advised Acentus in the acquisition of substantially all of its assets by Henry Schein, Inc. Acentus is a national medical supplier specializing in the delivery of Continuous Glucose Monitors (CGMs). Acentus Founders Brett Carroll, Todd Cianfrocca, Greg Duvall, and Julio Valdivia will join Henry Schein, bringing their expertise and experience in the product category and the healthcare industry.
Provident’s deal team was led by Managing Director Kevin Palamara. Robinson & Cole served as legal counsel to Acentus. The agreement to acquire Acentus was announced on November 20, 2024.
“Hats off to the entire Provident team. They brought unmatched expertise, experience, and dedication to the process and their guidance and professionalism throughout the transaction exceeded all our expectations,” commented CEO of Acentus Todd Cianfrocca .
“Congratulations to Acentus on this significant achievement. It has been a pleasure working alongside Todd and his entire team throughout this process,” commented Palamara.
“Todd and the Acentus team have developed a unique and differentiated CGM platform that has realized tremendous growth since its inception. We were proud to represent them through this process and are incredibly excited to see where this partnership with Henry Schein will take them going forward,” statedSenior Associate at Provident Brendan Schroeder.
